Research Article
Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
Table 4
Multivariate analysis of rivaroxaban and CRNMB in obese patients.
| |||||||||||||||||||||||||||||||||||||||
This table presents the multivariate logistical regression model for rivaroxaban and odds ratios for outcome of CRNMB in obese patients compared to normal weight controls in the NVAF cohort. |